Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — Bectas Therapeutics, Inc.

0002038826-25-000002 · filed Oct 8, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$10,000,000
Reported amount sold
$5,550,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Bectas Therapeutics, Inc.
CIK
2038826
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2022
Address
3262 WESTHEIMER ROAD
HOUSTON, Texas 77098
Phone
617-834-3476

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗